Endocrine Pharmacology Flashcards
What are the mechanisms by which drugs can work on the individual?
Receptor binding - agonist, antagonist, partial agonist Action on ion channels Action on enzyme Transporters Cytotoxic agents
What is the function of prolactin and how is secretion controlled?
It stimulates lactation
Secreted by the lactotrophs in the anterior pituitary, and is under negative feedback by dopamine
What can hyperprolactinaemia lead to?
Hypergonadotropic hypogonadism
List the drugs that can interfere with prolactin secretion, and why.
Antipsychotics - typical & atypical Antiemetics - domperidone Antidepressants - SSRIs Opiates H2 receptor antagonists - these affect prolactin because they all interfere with the action of dopamine
What is the most common tumour of the pituitary gland?
Prolactinoma
What size constitutes a macroadenoma (rather than a microadenoma)?
> 1cm
What medications will you give someone with a prolactinoma?
Dopamine (D2) Agonists
- cabergoline - long half life
- quinagolide
- bromocriptine - short half life
Where and why is ADH released?
Released from the anterior pituitary (peptide hormone) in response to low plasma volume or increased serum osmolality
What condition can occur when ADH isn’t produced or doesn’t have an effect on the kidney?
Diabetes insipidus.
- cranial (lack of ADH production)
- nephrogenic (ADH resistance in kidneys)
Where are V1 and V2 receptors for ADH located, and what are their functions?
V1 - vascular smooth muscle - allows vasoconstriction
V2 - receptors in distal tubule/collecting duct - adds AQ1 channels to reabsorb more water
What is desmopressin?
A synthetic analogue of ADH
What is the difference between ddAVP and ADH action?
ADH has a shorter half life and includes vasoconstrictor effects
What is the difference in the ways ddAVP can be administered?
For maintenance - oral, sublingual or intranasal
For acute therapy - subcutaneous, intramuscular or intravenous
Name and briefly describe two thionamide drugs.
Carbimazole- more common
- converted to methimazole via first pass metabolism
Propylthiouriacil
- less active with shorter half life
What is the mechanism of action of thionamides?
Inhibits thyroid peroxidase - Inhibits iodide oxidation - Inhibits iodination of tyrosine residues - Inhibits iodotyrosine coupling Takes weeks for effects to occur
What is different about the action of propythiouracil?
It also reduces T4 to T3 conversion in the periphery
Name four treatments other than medicine for hyperthyroidism.
Beta-blockers - just reduces sympathetic symptoms
Potassium iodide - acute reduction of thyroid hormone
Radioactive iodine
Surgery
Briefly describe T2DM pathology.
Insulin resistance
- usually develops due to a combination of lifestyle and genetic factors
- insulin signalling impaired at cellular level
Impaired insulin secretion
- initial hyperinsulinaemia can no longer cope with resistance, bet-cell failure occurs
What are the first, second and third line treatments for T2DM?
Lifestyle changes
1st - Metformin (Sulphonylureas)
2nd - ADD ONE OF: sulphonylureas (thiazolidinedione, DDP-IV inhibitor)
3rd - ADD OR SUBSTITUTE ONE OF: Thiazolidinedione, DDP-IV inhibitors, injected insulin or injected GLP-1 agonists
Mechanism of action of Metformin (a biguanide)
Inhibits mitochondrial glycerophosphate dehydrogenase in the liver and activates AMPK
- decreases gluconeogensis
- inhibits action of PEPCK and G6Pase
An insulin sensitiser
Pharmacokinetics of Sulphonylureas (Glicazide, gilpizide, glubenclamide)
Well absorbed, peak plasma concentration within 2-4 hours
Metabolised by the liver
Duration of action is up to 24 hours
Pharmacodynamics of Sulphonylureas (Glicazide, gilpizide, glubenclamide
Binds to its receptor on beta-cells and inhibits the KATP channels, causing the membrane to depolarise and cause insulin release.
- increases insulin
Pharmacokinetics of thiazolidinedione. (Pioglitazone, rosiglitazone)
Rapidly absorbed
Extensive hepatic metabolism
Pioglitazone is excreted in bile
Pharmacodynamics of thiazolidinedione. (Pioglitazone, rosiglitazone)
Bind to PPARgamma and increase transcription of insulin sensitising genes
- PPARgamma is a nuclear receptor expression in adipose tissues, muscle and the liver
- stimulates triglyceride synthesis in adipose tissue, preventing fat deposits in inappropriate places
- increases tissue sensitivity to insulin